{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:14:52Z","timestamp":1783332892376,"version":"3.54.6"},"reference-count":46,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100008358","name":"Hersenstichting","doi-asserted-by":"publisher","award":["HA2017.01.03"],"award-info":[{"award-number":["HA2017.01.03"]}],"id":[{"id":"10.13039\/501100008358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives\/Background<\/jats:title>\n                    <jats:p>Cluster headache (CH) has historically been considered a male\u2010dominated disorder, suggesting a role for androgens in its pathophysiology. We aimed to evaluate hormone profiles and symptoms of androgen deficiency in CH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, matched case\u2013control study with a nested repeated\u2010measures component, fasted morning blood samples were collected in 30 males with chronic CH (CCH), 33 males with episodic CH (ECH; both during episode and remission), and in 30 age\u2010matched male headache\u2010free controls (HCs). Surveys assessing symptoms of androgen deficiency (Quantitative Androgen Deficiency of Aging Males [QADAM], Aging Males' Symptoms [AMS]) were collected simultaneously. Steroid hormone profiles were compared among groups. The primary outcome was total testosterone (tT) including biochemical hypogonadism (tT \u2264\u200910.5). Secondary outcomes were hormonal pathways and individual hormones. Data were collected between October 2022 and April 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Biochemical hypogonadism was observed in 20% of participants with CCH (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096), in 9% with ECH (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), and in 7% of HCs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092). None of the HCs had severe hypogonadism, in contrast to those with CH (CCH,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093\/6; ECH,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091\/3). AMS and QADAM scores indicated more symptoms of androgen deficiency in participants with hypogonadism, in ECH (AMS: B\u2009=\u20099.59 [95% CI\u2009=\u20095.69\u201313.50],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; QADAM: B\u2009=\u2009\u22125.25 [95% CI = \u22127.39 to \u22123.11],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and CCH (AMS: B\u2009=\u20098.78 [95% CI\u2009=\u20094.45\u201313.12],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; QADAM: B\u2009=\u2009\u22124.59 [95% CI = \u22126.97 to \u22122.22],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared to HCs. In the unadjusted model, we observed a lower, albeit non\u2010statistically significant, mean tT in participants with CCH versus HCs (CCH: B\u2009=\u2009\u22122.35\u2009nmol\/L [95% CI = \u22124.79 to 0.09],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.059). In the adjusted model, the differences attenuated, suggesting a strong effect of body mass index and age on the mean tT (CCH: B\u2009=\u2009\u22120.93\u2009nmol\/L [95% CI = \u22123.81 to 1.95],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.524; ECH: B\u2009=\u20090.55\u2009nmol\/L [95% CI = \u22122.05 to 3.15],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.674). Measures of hormonal pathways and individual hormones did not differ among groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Biochemical hypogonadism was observed in one out of five males with CCH versus one out of 20 in the ECH and HCs. Apart from one case, gonadotrophin concentrations were not increased, suggesting a central origin. In the crude data we observed a lower, albeit non\u2010statistically significant, mean tT in males with CCH, but this appeared to be mainly driven by body mass index and age, because it attenuated after correction. Clinical symptoms of androgen deficiency were more prevalent in CH compared to HCs, independent of hypogonadism. Physicians should be aware of potential increased risk and symptoms of (central) hypogonadism in CCH. Further investigation should explore shared underlying mechanisms and testosterone supplementation in CH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.70174","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:24:35Z","timestamp":1783329875000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case\u2013control study"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9260-9336","authenticated-orcid":false,"given":"Willemijn C.","family":"Naber","sequence":"first","affiliation":[{"name":"Department of Neurology Leiden University Medical Centre (LUMC)  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4872","authenticated-orcid":false,"given":"Roemer B.","family":"Brandt","sequence":"additional","affiliation":[{"name":"Department of Neurology Leiden University Medical Centre (LUMC)  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebl","family":"Leon Morales\u2010Grooters","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Diagnostic Laboratory for Endocrinology Erasmus Medical Center Rotterdam  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"van der Wal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Diagnostic Laboratory for Endocrinology Erasmus Medical Center Rotterdam  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd A. A.","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Diagnostic Laboratory for Endocrinology Erasmus Medical Center Rotterdam  Rotterdam the Netherlands"},{"name":"Department of Clinical Chemistry Erasmus Medical Center  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle J.","family":"Goeman","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Sciences Leiden University Medical Centre (LUMC)  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette Maassen","family":"van den Brink","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine and Pharmacology, Department of Internal Medicine Erasmus University Medical Center  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fronczek","sequence":"additional","affiliation":[{"name":"Department of Neurology Leiden University Medical Centre (LUMC)  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"e1207","article-title":"Sex differences in clinical features, treatment, and lifestyle factors in patients with cluster headache","volume":"100","author":"Fourier C","year":"2022","journal-title":"Neurology"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1468-2982.2002.00318.x","article-title":"Age at onset and sex ratio in cluster headache: observations over three decades","volume":"22","author":"Ekbom K","year":"2002","journal-title":"Cephalalgia"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1526-4610.1972.hed1104175.x","article-title":"Cluster headache","volume":"11","author":"Graham JR","year":"1972","journal-title":"Headache"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1468-2982.1986.0601029.x","article-title":"Reduced testosterone levels in cluster headache: a stress\u2010related phenomenon?","volume":"6","author":"Facchinetti F","year":"1986","journal-title":"Cephalalgia"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1468-2982.1983.0301041.x","article-title":"Low plasma testosterone levels in cluster headache","volume":"3","author":"Romiti A","year":"1983","journal-title":"Cephalalgia"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1526-4610.1982.hed2204162.x","article-title":"Plasma testosterone levels in patients with cluster headache","volume":"22","author":"Klimek A","year":"1982","journal-title":"Headache"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1526-4610.1978.hed1805265.x","article-title":"Testosterone levels in cluster and non\u2010cluster migrainous headache patients","volume":"18","author":"Nelson RF","year":"1978","journal-title":"Headache"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1468-2982.1989.902091.x","article-title":"Cluster headache in the male: sex steroid pattern and gonadotropic response to luteinizing hormone releasing hormone","volume":"9","author":"Murialdo G","year":"1989","journal-title":"Cephalalgia"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1526-4610.2006.00436.x","article-title":"Testosterone replacement therapy for treatment refractory cluster headache","volume":"46","author":"Stillman MJ","year":"2006","journal-title":"Headache"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1468-2982.1987.0701043.x","article-title":"Prolactin in cluster headache: diurnal secretion, response to thyrotropin\u2010releasing hormone, and relation to sex steroids and gonadotropins","volume":"7","author":"Waldenlind E","year":"1987","journal-title":"Cephalalgia"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jnnp.2005.081158","article-title":"Cluster headache in women: relation with menstruation, use of oral contraceptives, pregnancy, and menopause","volume":"77","author":"Vliet JA","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1093\/ejendo\/lvad047","article-title":"The clinical and biochemical significance of 11\u2010oxygenated androgens in human health and disease","volume":"188","author":"Storbeck KH","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70022","article-title":"Exploring the predictive role of 11\u2010oxyandrogens in diagnosing polycystic ovary syndrome","volume":"8","author":"Mody AP","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ana.26906","article-title":"Compensated hypogonadism identified in males with cluster headache: a prospective case\u2010controlled study","volume":"95","author":"Petersen AS","year":"2024","journal-title":"Ann Neurol"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021881","article-title":"Activins and Inhibins: roles in development, physiology, and disease","volume":"8","author":"Namwanje M","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0333102413479835","article-title":"Stepwise web\u2010based questionnaires for diagnosing cluster headache: LUCA and QATCH","volume":"33","author":"Wilbrink LA","year":"2013","journal-title":"Cephalalgia"},{"key":"e_1_2_8_18_1","first-page":"1","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","journal-title":"Cephalalgia"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/00912700022009486","article-title":"Modeling of circadian testosterone in healthy males and hypogonadal men","volume":"40","author":"Gupta SK","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_8_20_1","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12995","article-title":"Serum testosterone levels in male hypogonadism: why and when to check\u2014a review","volume":"71","author":"Livingston M","year":"2017","journal-title":"Int J Clin Pract"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen A","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_22_1","first-page":"34","article-title":"Aging males' symptoms scale: a standardized instrument for the practice","volume":"28","author":"Heinemann LA","year":"2005","journal-title":"J Endocrinol Investig"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-1-77","article-title":"The aging males' symptoms (AMS) scale: review of its methodological characteristics","volume":"1","author":"Daig I","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ijir.2009.35","article-title":"The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism","volume":"22","author":"Mohamed O","year":"2010","journal-title":"Int J Impot Res"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/13685530412331284650","article-title":"Hormone profiles, body mass index and aging male symptoms: results of the Androx Vienna municipality study","volume":"7","author":"Kratzik CW","year":"2004","journal-title":"Aging Male"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.14310\/horm.2002.1445","article-title":"Cigarette smoking has a positive and independent effect on testosterone levels","volume":"12","author":"Wang W","year":"2013","journal-title":"Hormones (Athens)"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ejendo\/lvae133","article-title":"Sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta\u2010analyses","volume":"191","author":"Narinx N","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109346","article-title":"A validated age\u2010related normative model for male total testosterone shows increasing variance but no decline after age 40\u2009years","volume":"9","author":"Kelsey TW","year":"2014","journal-title":"PLoS One"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale. An updated literature review","volume":"52","author":"Bjelland I","year":"2002","journal-title":"J Psychosom Res"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-021-01334-3","article-title":"Clinical symptoms of androgen deficiency in males with migraine or cluster headache: a cross\u2010sectional cohort study","volume":"22","author":"Verhagen IE","year":"2021","journal-title":"J Headache Pain"},{"key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2016-2935","article-title":"Harmonized reference ranges for circulating testosterone levels in males of four cohort studies in the United States and Europe","volume":"102","author":"Travison TG","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in males with hypogonadism: an endocrine Society clinical practice guideline","volume":"103","author":"Bhasin S","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bioinformatics\/btg382","article-title":"A global test for groups of genes: testing association with a clinical outcome","volume":"20","author":"Goeman JJ","year":"2004","journal-title":"Bioinformatics"},{"key":"e_1_2_8_34_1","first-page":"e374","article-title":"Female sex hormones in males with migraine","volume":"91","author":"Oosterhout WPJ","year":"2018","journal-title":"Neurology"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(24)00143-1","article-title":"Recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headache","volume":"23","author":"Petersen AS","year":"2024","journal-title":"Lancet Neurol"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","article-title":"PACAP and its role in primary headaches","volume":"19","author":"Edvinsson L","year":"2018","journal-title":"J Headache Pain"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.993228","article-title":"Stereology of gonadotropin\u2010releasing hormone and kisspeptin neurons in PACAP gene\u2010deficient female mice","volume":"13","author":"Barab\u00e1s K","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0333102413487445","article-title":"Hypothalamic dopaminergic stimulation in cluster headache","volume":"33","author":"Lepper A","year":"2013","journal-title":"Cephalalgia"},{"key":"e_1_2_8_39_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-016-0614-0","article-title":"Chronic cluster headache and the pituitary gland","volume":"17","author":"De Pue A","year":"2016","journal-title":"J Headache Pain"},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.12998\/wjcc.v9.i14.3294","article-title":"Cluster headache due to structural lesions: a systematic review of published cases","volume":"9","author":"Long RJ","year":"2021","journal-title":"World J Clin Cases"},{"key":"e_1_2_8_41_1","doi-asserted-by":"crossref","DOI":"10.1177\/2514183X20925956","article-title":"Cluster headache and anxiety: results of the EUROLIGHT cluster headache project\u2014an internet\u2010based, cross\u2010sectional study of people with cluster headache","volume":"4","author":"Pohl H","year":"2020","journal-title":"Clin Transl Neurosci"},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/jc.2008-1902","article-title":"The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men","volume":"94","author":"Brambilla DJ","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1468-2982.1993.1305309.x","article-title":"A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement","volume":"13","author":"Leone M","year":"1993","journal-title":"Cephalalgia"},{"key":"e_1_2_8_44_1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1526-4610.1992.hed3204184.x","article-title":"Episodic cluster headache. II: high tobacco and alcohol consumption in males","volume":"32","author":"Levi R","year":"1992","journal-title":"Headache"},{"key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3988\/jcn.2021.17.2.229","article-title":"Smoking history and clinical features of cluster headache: results from the Korean Cluster Headache Registry","volume":"17","author":"Chung PW","year":"2021","journal-title":"J Clin Neurol"},{"key":"e_1_2_8_46_1","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213795","article-title":"Exploration of prolonged remission and the natural course of cluster headache: an interview\u2010based cohort study","volume":"105","author":"Naber W","year":"2025","journal-title":"Neurology"},{"key":"e_1_2_8_47_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ana.26743","article-title":"Cluster headache genomewide association study and meta\u2010analysis identifies eight loci and implicates smoking as causal risk factor","volume":"94","author":"Winsvold BS","year":"2023","journal-title":"Ann Neurol"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.70174","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.70174","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.70174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:24:42Z","timestamp":1783329882000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.70174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":46,"alternative-id":["10.1111\/head.70174"],"URL":"https:\/\/doi.org\/10.1111\/head.70174","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"2025-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"head.70174"}}